Browse > Article
http://dx.doi.org/10.5483/BMBRep.2011.44.3.158

Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models  

Lim, Sang-Kyun (Department of Developmental Biology, The University of Texas Southwestern Medical Center at Dallas)
Llaguno, Sheila R. Alcantara (Department of Developmental Biology, The University of Texas Southwestern Medical Center at Dallas)
McKay, Renee M. (Department of Developmental Biology, The University of Texas Southwestern Medical Center at Dallas)
Parada, Luis F. (Department of Developmental Biology, The University of Texas Southwestern Medical Center at Dallas)
Publication Information
BMB Reports / v.44, no.3, 2011 , pp. 158-164 More about this Journal
Abstract
Gliomas are the most frequently occurring primary malignancies in the central nervous system, and glioblastoma multiforme (GBM) is the most common and most aggressive of these tumors. Despite vigorous basic and clinical studies over past decades, the median survival of patients with this disease remains at about one year. Recent studies have suggested that GBMs contain a subpopulation of tumor cells that displays stem cell characteristics and could therefore be responsible for in vivo tumor growth. We will summarize the major oncogenic pathways abnormally regulated in gliomas, and review the recent findings from mouse models that our laboratory as well as others have developed for the study of GBM. The concept of cancer stem cells in GBM and their potential therapeutic importance will also be discussed.
Keywords
Glioblastoma; Glioma; Glioma stem cells; Mouse models of glioma;
Citations & Related Records

Times Cited By Web Of Science : 10  (Related Records In Web of Science)
Times Cited By SCOPUS : 6
연도 인용수 순위
1 Reynolds, B. A., Tetzlaff, W. and Weiss, S. (1992) A multipotentEGF-responsive striatal embryonic progenitor cellproduces neurons and astrocytes. J. Neurosci. 12, 4565-4574.
2 Reynolds, B. A. and Weiss, S. (1996) Clonal and populationanalyses demonstrate that an EGF-responsivemammalian embryonic CNS precursor is a stem cell. Dev.Biol. 175, 1-13.   DOI   ScienceOn
3 Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir,I. R., Lu, L., Irvin, D., Black, K. L. and Yu, J. S. (2006)Analysis of gene expression and chemoresistance of$CD133^+$ cancer stem cells in glioblastoma. Mol. Cancer5, 67.   DOI   ScienceOn
4 Salmaggi, A., Boiardi, A., Gelati, M., Russo, A., Calatozzolo,C., Ciusani, E., Sciacca, F. L., Ottolina, A., Parati, E.A., La Porta, C., Alessandri, G., Marras, C., Croci, D. andDe Rossi, M. (2006) Glioblastoma-derived tumorospheresidentify a population of tumor stem-like cells with angiogenicpotential and enhanced multidrug resistancephenotype. Glia 54, 850-860.   DOI   ScienceOn
5 Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q.,Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D. andRich, J. N. (2006) Glioma stem cells promote radioresistanceby preferential activation of the DNA damageresponse. Nature 444, 756-760.   DOI   ScienceOn
6 Piccirillo, S. G., Reynolds, B. A., Zanetti, N., Lamorte, G.,Binda, E., Broggi, G., Brem, H., Olivi, A., Dimeco, F. andVescovi, A. L. (2006) Bone morphogenetic proteins inhibitthe tumorigenic potential of human brain tumour-initiatingcells. Nature 444, 761-765.   DOI   ScienceOn
7 Lukacs, R. U., Memarzadeh, S., Wu, H. and Witte, O. N.(2010) Bmi-1 is a crucial regulator of prostate stem cellself-renewal and malignant transformation. Cell Stem Cell7, 682-693.   DOI   ScienceOn
8 Cameron, H. A., Woolley, C. S., McEwen, B. S. andGould, E. (1993) Differentiation of newly born neuronsand glia in the dentate gyrus of the adult rat. Neuroscience56, 337-344.   DOI   ScienceOn
9 Kaplan, M. S. and Hinds, J. W. (1977) Neurogenesis in theadult rat: electron microscopic analysis of light radioautographs.Science 197, 1092-1094.   DOI
10 Reya, T., Morrison, S. J., Clarke, M. F. and Weissman, I. L.(2001) Stem cells, cancer, and cancer stem cells. Nature414, 105-111.   DOI   ScienceOn
11 Kamel-Reid, S., Letarte, M., Sirard, C., Doedens, M.,Grunberger, T., Fulop, G., Freedman, M. H., Phillips, R.A. and Dick, J. E. (1989) A model of human acute lymphoblastic leukemia in immune-deficient SCID mice.Science 246, 1597-1600.   DOI
12 Sirard, C., Lapidot, T., Vormoor, J., Cashman, J. D.,Doedens, M., Murdoch, B., Jamal, N., Messner, H.,Addey, L., Minden, M., Laraya, P., Keating, A., Eaves, A.,Lansdorp, P. M., Eaves, C. J. and Dick, J. E. (1996) Normaland leukemic SCID-repopulating cells (SRC) coexist in thebone marrow and peripheral blood from CML patients inchronic phase, whereas leukemic SRC are detected inblast crisis. Blood 87, 1539-1548.
13 Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang,T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri,M. A. and Dick, J. E. (1994) A cell initiating human acutemyeloid leukaemia after transplantation into SCID mice.Nature 367, 645-648.   DOI   ScienceOn
14 Singh, S. K., Clarke, I. D., Terasaki, M., Bonn, V. E., Hawkins,C., Squire, J. and Dirks, P. B. (2003) Identification ofa cancer stem cell in human brain tumors. Cancer Res.63, 5821-5828.
15 Cotsarelis, G., Sun, T. T. and Lavker, R. M. (1990)Label-retaining cells reside in the bulge area of pilosebaceousunit: implications for follicular stem cells, hair cycle,and skin carcinogenesis. Cell 61, 1329-1337.   DOI   ScienceOn
16 Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A.,Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D.and Dirks, P. B. (2004) Identification of human brain tumourinitiating cells. Nature 432, 396-401.   DOI   ScienceOn
17 Shackleton, M., Vaillant, F., Simpson, K. J., Stingl, J., Smyth, G. K., Asselin-Labat, M. L., Wu, L., Lindeman, G.J. and Visvader, J. E. (2006) Generation of a functionalmammary gland from a single stem cell. Nature 439, 84-88.   DOI   ScienceOn
18 Kim, C. F., Jackson, E. L., Woolfenden, A. E., Lawrence,S., Babar, I., Vogel, S., Crowley, D., Bronson, R. T. andJacks, T. (2005) Identification of bronchioalveolar stemcells in normal lung and lung cancer. Cell 121, 823-835.   DOI   ScienceOn
19 Collins, A. T., Habib, F. K., Maitland, N. J. and Neal, D. E.(2001) Identification and isolation of human prostate epithelialstem cells based on alpha(2)beta(1)-integrin expression.J. Cell Sci. 114, 3865-3872.
20 Morrison, S. J. and Weissman, I. L. (1994) The long-termrepopulating subset of hematopoietic stem cells is deterministicand isolatable by phenotype. Immunity 1,661-673.   DOI   ScienceOn
21 Morrison, S. J., Wandycz, A. M., Hemmati, H. D., Wright,D. E. and Weissman, I. L. (1997) Identification of a lineageof multipotent hematopoietic progenitors. Development124, 1929-1939.
22 Morrison, S. J., Wright, D. E., Cheshier, S. H. andWeissman, I. L. (1997) Hematopoietic stem cells: challengesto expectations. Curr. Opin. Immunol. 9, 216-221.   DOI   ScienceOn
23 Tohma, Y., Gratas, C., Biernat, W., Peraud, A., Fukuda,M., Yonekawa, Y., Kleihues, P. and Ohgaki, H. (1998)PTEN (MMAC1) mutations are frequent in primary glioblastomas(de novo) but not in secondary glioblastomas. JNeuropath Exp Neurol 57, 684-689.   DOI
24 Tsujimura, A., Koikawa, Y., Salm, S., Takao, T., Coetzee,S., Moscatelli, D., Shapiro, E., Lepor, H., Sun, T. T. andWilson, E. L. (2002) Proximal location of mouse prostateepithelial stem cells: a model of prostatic homeostasis. J.Cell Biol. 157, 1257-1265.   DOI   ScienceOn
25 Goto, K., Salm, S. N., Coetzee, S., Xiong, X., Burger, P. E.,Shapiro, E., Lepor, H., Moscatelli, D. and Wilson, E. L.(2006) Proximal prostatic stem cells are programmed toregenerate a proximal-distal ductal axis. Stem Cells 24,1859-1868.   DOI   ScienceOn
26 Kwon, C. H., Zhao, D., Chen, J., Alcantara, S., Li, Y.,Burns, D. K., Mason, R. P., Lee, E. Y., Wu, H. and Parada,L. F. (2008) Pten haploinsufficiency accelerates formationof high-grade astrocytomas. Cancer Res. 68, 3286-3294.   DOI   ScienceOn
27 Chen, J., Kwon, C. H., Lin, L., Li, Y. and Parada, L. F.(2009) Inducible site-specific recombination in neuralstem/progenitor cells. Genesis 47, 122-131.   DOI   ScienceOn
28 Alcantara Llaguno, S., Chen, J., Kwon, C. H., Jackson, E.L., Li, Y., Burns, D. K., Alvarez-Buylla, A. and Parada, L.F. (2009) Malignant astrocytomas originate from neuralstem/progenitor cells in a somatic tumor suppressormouse model. Cancer Cell 15, 45-56.   DOI   ScienceOn
29 Barker, N., van Es, J. H., Kuipers, J., Kujala, P., van denBorn, M., Cozijnsen, M., Haegebarth, A., Korving, J.,Begthel, H., Peters, P. J. and Clevers, H. (2007) Identificationof stem cells in small intestine and colon by markergene Lgr5. Nature 449, 1003-1007.   DOI   ScienceOn
30 Cornelius, J. G., Tchernev, V., Kao, K. J. and Peck, A. B.(1997) In vitro-generation of islets in long-term cultures ofpluripotent stem cells from adult mouse pancreas. HormMetab. Res. 29, 271-277.   DOI   ScienceOn
31 Verhaak, R. G., Hoadley, K. A., Purdom, E., Wang, V., Qi,Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T.,Mesirov, J. P., Alexe, G., Lawrence, M., O'Kelly, M.,Tamayo, P., Weir, B. A., Gabriel, S., Winckler, W., Gupta,S., Jakkula, L., Feiler, H. S., Hodgson, J. G., James, C. D.,Sarkaria, J. N., Brennan, C., Kahn, A., Spellman, P. T.,Wilson, R. K., Speed, T. P., Gray, J. W., Meyerson, M.,Getz, G., Perou, C. M. and Hayes, D. N. (2010) Integratedgenomic analysis identifies clinically relevant subtypes ofglioblastoma characterized by abnormalities in PDGFRA,IDH1, EGFR, and NF1. Cancer Cell 17, 98-110.   DOI   ScienceOn
32 Doetsch, F., Caille, I., Lim, D. A., Garcia-Verdugo, J. M.and Alvarez-Buylla, A. (1999) Subventricular zone astrocytesare neural stem cells in the adult mammalianbrain. Cell 97, 703-716.   DOI   ScienceOn
33 Gage, F. H., Coates, P. W., Palmer, T. D., Kuhn, H. G.,Fisher, L. J., Suhonen, J. O., Peterson, D. A., Suhr, S. T.and Ray, J. (1995) Survival and differentiation of adultneuronal progenitor cells transplanted to the adult brain.Proc. Natl. Acad. Sci. U.S.A. 92, 11879-11883.   DOI
34 Taniguchi, H., Toyoshima, T., Fukao, K. and Nakauchi, H.(1996) Presence of hematopoietic stem cells in the adultliver. Nat. Med. 2, 198-203.   DOI   ScienceOn
35 Holland, E. C., Celestino, J., Dai, C., Schaefer, L., Sawaya,R. E. and Fuller, G. N. (2000) Combined activation of Rasand Akt in neural progenitors induces glioblastoma formationin mice. Nat Genet 25, 55-57.   DOI   ScienceOn
36 Marumoto, T., Tashiro, A., Friedmann-Morvinski, D.,Scadeng, M., Soda, Y., Gage, F. H. and Verma, I. M.(2009) Development of a novel mouse glioma model usinglentiviral vectors. Nat. Med. 15, 110-116.   DOI   ScienceOn
37 Jacques, T. S., Swales, A., Brzozowski, M. J., Henriquez,N. V., Linehan, J. M., Mirzadeh, Z., O'Malley, C., Naumann, H., Alvarez-Buylla, A. and Brandner, S. (2009)Combinations of genetic mutations in the adult neuralstem cell compartment determine brain tumour phenotypes.EMBO J. 29, 222-235.
38 Zhu, Y., Guignard, F., Zhao, D., Liu, L., Burns, D. K.,Mason, R. P., Messing, A. and Parada, L. F. (2005) Earlyinactivation of p53 tumor suppressor gene cooperatingwith NF1 loss induces malignant astrocytoma. Cancer cell8, 119-130.   DOI   ScienceOn
39 Bachoo, R. M., Maher, E. A., Ligon, K. L., Sharpless, N. E.,Chan, S. S., You, M. J., Tang, Y., DeFrances, J., Stover, E.,Weissleder, R., Rowitch, D. H., Louis, D. N. andDePinho, R. A. (2002) Epidermal growth factor receptorand Ink4a/Arf: convergent mechanisms governing terminaldifferentiation and transformation along the neuralstem cell to astrocyte axis. Cancer Cell 1, 269-277.   DOI   ScienceOn
40 Bruggeman, S. W., Hulsman, D., Tanger, E., Buckle, T.,Blom, M., Zevenhoven, J., van Tellingen, O. and vanLohuizen, M. (2007) Bmi1 controls tumor development inan Ink4a/Arf-independent manner in a mouse model forglioma. Cancer Cell 12, 328-341.   DOI   ScienceOn
41 Parsons, D. W., Jones, S., Zhang, X., Lin, J. C., Leary, R. J.,Angenendt, P., Mankoo, P., Carter, H., Siu, I. M., Gallia, G. L., Olivi, A., McLendon, R., Rasheed, B. A., Keir, S.,Nikolskaya, T., Nikolsky, Y., Busam, D. A., Tekleab, H.,Diaz, L. A., Jr., Hartigan, J., Smith, D. R., Strausberg, R. L.,Marie, S. K., Shinjo, S. M., Yan, H., Riggins, G. J., Bigner,D. D., Karchin, R., Papadopoulos, N., Parmigiani, G.,Vogelstein, B., Velculescu, V. E. and Kinzler, K. W. (2008)An integrated genomic analysis of human glioblastomamultiforme. Science 321, 1807-1812.   DOI   ScienceOn
42 Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed,B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S.,Riggins, G. J., Friedman, H., Friedman, A., Reardon, D.,Herndon, J., Kinzler, K. W., Velculescu, V. E., Vogelstein,B. and Bigner, D. D. (2009) IDH1 and IDH2 mutations ingliomas. N. Engl. J. Med. 360, 765-773.   DOI   ScienceOn
43 Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger,M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin,S., Keenan, M. C., Marks, K. M., Prins, R. M., Ward, P. S.,Yen, K. E., Liau, L. M., Rabinowitz, J. D., Cantley, L. C.,Thompson, C. B., Vander Heiden, M. G. and Su, S. M.(2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739-744.   DOI   ScienceOn
44 Ohgaki, H. and Kleihues, P. (2007) Genetic pathways toprimary and secondary glioblastoma. Am. J. Pathol. 170,1445-1453.   DOI   ScienceOn
45 Zhao, S., Lin, Y., Xu, W., Jiang, W., Zha, Z., Wang, P., Yu,W., Li, Z., Gong, L., Peng, Y., Ding, J., Lei, Q., Guan, K.L. and Xiong, Y. (2009) Glioma-derived mutations inIDH1 dominantly inhibit IDH1 catalytic activity and induceHIF-1alpha. Science 324, 261-265.   DOI   ScienceOn
46 Phillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F.,Soriano, R. H., Wu, T. D., Misra, A., Nigro, J. M., Colman,H., Soroceanu, L., Williams, P. M., Modrusan, Z.,Feuerstein, B. G. and Aldape, K. (2006) Molecular subclassesof high-grade glioma predict prognosis, delineate apattern of disease progression, and resemble stages inneurogenesis. Cancer Cell 9, 157-173.   DOI   ScienceOn
47 Carro, M. S., Lim, W. K., Alvarez, M. J., Bollo, R. J., Zhao,X., Snyder, E. Y., Sulman, E. P., Anne, S. L., Doetsch, F.,Colman, H., Lasorella, A., Aldape, K., Califano, A. andIavarone, A. (2010) The transcriptional network for mesenchymaltransformation of brain tumours. Nature 463,318-325.   DOI   ScienceOn
48 Alcantara Llaguno, S. R., Chen, J. and Parada, L. F. (2009)Signaling in malignant astrocytomas: role of neural stemcells and its therapeutic implications. Clin. Cancer Res.15, 7124-7129.   DOI   ScienceOn
49 Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A.,Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L.,Louis, D. N., Brennan, C., Chin, L., DePinho, R. A. andCavenee, W. K. (2007) Malignant astrocytic glioma: genetics,biology, and paths to treatment. Genes Dev. 21,2683-2710.   DOI   ScienceOn
50 TCGA (2008) Comprehensive genomic characterizationdefines human glioblastoma genes and core pathways.Nature 455, 1061-1068.   DOI   ScienceOn
51 Le, L. Q. and Parada, L. F. (2007) Tumor microenvironmentand neurofibromatosis type I: connecting the GAPs.Oncogene 26, 4609-4616.   DOI   ScienceOn
52 The Cancer Genome Atlas Research Network. (2008) Comprehensivegenomic characterization defines human glioblastomagenes and core pathways. Nature 455, 1061-1068.   DOI   ScienceOn
53 Gutmann, D. H., Rasmussen, S. A., Wolkenstein, P.,MacCollin, M. M., Guha, A., Inskip, P. D., North, K. N.,Poyhonen, M., Birch, P. H. and Friedman, J. M. (2002)Gliomas presenting after age 10 in individuals with neurofibromatosistype 1 (NF1). Neurology 59, 759-761.   DOI   ScienceOn
54 Cully, M., You, H., Levine, A. J. and Mak, T. W. (2006)Beyond PTEN mutations: the PI3K pathway as an integratorof multiple inputs during tumorigenesis. Nat. Rev.Cancer 6, 184-192.   DOI   ScienceOn
55 Ichimura, K., Ohgaki, H., Kleihues, P. and Collins, V. P.(2004) Molecular pathogenesis of astrocytic tumours. J.Neurooncol. 70, 137-160.   DOI   ScienceOn
56 Louis, D. N. (2006) Molecular pathology of malignantgliomas. Annu. Rev. Pathol. 1, 97-117.   DOI   ScienceOn
57 Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M.,Fisher, B., Taphoorn, M. J., Belanger, K., Brandes, A. A.,Marosi, C., Bogdahn, U., Curschmann, J., Janzer, R. C.,Ludwin, S. K., Gorlia, T., Allgeier, A., Lacombe, D.,Cairncross, J. G., Eisenhauer, E. and Mirimanoff, R. O.(2005) Radiotherapy plus concomitant and adjuvant temozolomidefor glioblastoma. N. Engl. J. Med. 352, 987-996.   DOI   ScienceOn
58 Kleihues, P. and Cavenee, W. K. (2000) Pathology andGenetics of Tumours of the Nervous System; in: WorldHealth Organization Classification of Tumors (Kleihues,P. and Sobin, L. H., eds.), IARC Press, Lyon, France.
59 Maher, E. A., Furnari, F. B., Bachoo, R. M., Rowitch, D.H., Louis, D. N., Cavenee, W. K. and DePinho, R. A.(2001) Malignant glioma: genetics and biology of a gravematter. Genes Dev. 15, 1311-1333.   DOI   ScienceOn
60 Zhu, Y. and Parada, L. F. (2002) The molecular and geneticbasis of neurological tumours. Nat. Rev. Cancer 2,616-626.   DOI   ScienceOn